Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT06567782 |
Title | A Study of Neoadjuvant Dostarlimab Plus Capecitabine Plus Oxaliplatin (CAPEOX) Vs CAPEOX With Previously Untreated T4N0 or Stage III Mismatch Repair Proficient (MMRp)/Microsatellite Stable (MSS) Colon Cancer (AZUR-4) |
Acronym | AZUR-4 |
Recruitment | Not yet recruiting |
Gender | both |
Phase | Phase II |
Variant Requirements | Yes |
Sponsors | GlaxoSmithKline |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | GBR | ESP | BEL |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
GSK Investigational Site | Aalst | 9300 | Belgium | Details | ||
GSK Investigational Site | Bonheiden | 2820 | Belgium | Details | ||
GSK Investigational Site | Bruxelles | 1070 | Belgium | Details | ||
GSK Investigational Site | Bruxelles | 1200 | Belgium | Details | ||
GSK Investigational Site | Gent | 9000 | Belgium | Details | ||
GSK Investigational Site | Leuven | 3000 | Belgium | Details | ||
GSK Investigational Site | LiEge | 4000 | Belgium | Details | ||
GSK Investigational Site | Liege | 4000 | Belgium | Details | ||
GSK Investigational Site | Roeselare | 8800 | Belgium | Details | ||
GSK Investigational Site | Barcelona | 8035 | Spain | Details | ||
GSK Investigational Site | Madrid | 28222 | Spain | Details | ||
GSK Investigational Site | Glasgow | G12 0YN | United Kingdom | Details | ||
GSK Investigational Site | Leeds West Yorkshire | LS9 7TF | United Kingdom | Details | ||
GSK Investigational Site | London | NW1 2PG | United Kingdom | Details | ||
GSK Investigational Site | Sutton | SM2 5PT | United Kingdom | Details |